184 related articles for article (PubMed ID: 31269905)
1. Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China.
Ye X; Li T; Shao W; Zeng J; Hong W; Lu L; Zhu W; Li C; Li T
BMC Infect Dis; 2019 Jul; 19(1):574. PubMed ID: 31269905
[TBL] [Abstract][Full Text] [Related]
2. Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing.
Deng X; Guo X; Li T; Laperche S; Zang L; Candotti D
Blood Transfus; 2022 Jan; 20(1):8-17. PubMed ID: 33370226
[TBL] [Abstract][Full Text] [Related]
3. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.
Kang JW; Seo JH; Youn KW; Seo YI; Huh K; Choi GR; Min HK; Oh DJ; Jo HJ; Kim JN
Vox Sang; 2017 Oct; 112(7):622-627. PubMed ID: 28891069
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of occult hepatitis B virus infection associated with envelope protein mutations according to anti-HBs carriage in blood donors.
Wang J; Zhang P; Zeng J; Du P; Zheng X; Ye X; Zhu W; Fu Y; Candotti D; Allain JP; Li C; Li T
Int J Infect Dis; 2020 Mar; 92():38-45. PubMed ID: 31877352
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
7. High-Frequency Notable HBV Mutations Identified in Blood Donors With Occult Hepatitis B Infection From Heyuan City of Southern China.
Ye X; Liu L; Chen L; Nie X; Huang L; Ye D; Zeng J; Li T; Li B; Xu M; Chen L
Front Immunol; 2022; 13():754383. PubMed ID: 35634299
[TBL] [Abstract][Full Text] [Related]
8. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
Seed CR; Kiely P
Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710
[TBL] [Abstract][Full Text] [Related]
9. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China.
Ye X; Li T; Li Y; Zeng J; Li R; Xu X; Guan X; Li L
Transfus Med; 2023 Feb; 33(1):81-89. PubMed ID: 36815535
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
Brojer E; Grabarczyk P; Liszewski G; Mikulska M; Allain JP; Letowska M;
Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474
[TBL] [Abstract][Full Text] [Related]
14. Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection.
Chamni N; Louisirirotchanakul S; Oota S; Sakuldamrongpanish T; Saldanha J; Chongkolwatana V; Phikulsod S
Vox Sang; 2014 Nov; 107(4):324-32. PubMed ID: 25040474
[TBL] [Abstract][Full Text] [Related]
15. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
[TBL] [Abstract][Full Text] [Related]
16. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.
Seed CR; Maloney R; Kiely P; Bell B; Keller AJ; Pink J;
Vox Sang; 2015 Feb; 108(2):113-22. PubMed ID: 25234417
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of occult hepatitis B cases in Greek blood donors.
Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China.
Liao H; Liu Y; Chen J; Ding W; Li X; Xu Z; Yang Y; Chen R; Si L; Xu X; Guo J; Xu D
Transfusion; 2017 Mar; 57(3pt2):857-866. PubMed ID: 28236303
[TBL] [Abstract][Full Text] [Related]
19. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
